A Nature analysis finds that even the latest AI agents fall short in creative, multi-step scientific problem-solving, with humans excelling in experiment design and troubleshooting. Benchmarks like ...
The latest generation of AI agents can draft code, summarize papers, and churn through datasets at speeds no human can match.
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
Scripps Research professors Carmel Valley resident John Yates III, the John Lytton Young Endowed Chair, and Jeffery Kelly, ...
The saying "cold hands, warm heart" is usually meant metaphorically—but new research from UC Davis School of Medicine and ...
Chinese tech giant fields teams in Boston, Rio de Janeiro and Barcelona as its unit unveils frameworks and therapies powered ...
ByteDance's drug-discovery unit, Anew Labs, is presenting its artificial intelligence-designed therapies at international ...
The adoption of AI is particularly critical to consider in research, as findings in scientific inquiry fundamentally shape ...
What happens when natural selection, the most powerful process driving change in the living world, shapes artificial ...
Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that ...
In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...